In the present study, we combined a well-established murine breast cancer model with a flow-restriction deep vein thrombosis (DVT) model (31) to interrogate whether the inhibition of IL-1β could attenuate cancer-associated thrombosis. The gene discussed is IL1B; the disease is breast cancer.